Clinical Trials Logo

Tinea clinical trials

View clinical trials related to Tinea.

Filter by:

NCT ID: NCT01524432 Completed - Tinea Pedis Clinical Trials

Hygienic Socks With Antifungal Agent-loaded Microcapsules for Patients With Tinea Pedis

Start date: January 2012
Phase: Phase 1
Study type: Interventional

This is a study of hygienic socks with antifungal agent-loaded microcapsules for subjects with interdigital type tinea pedis (athlete's foot between the toes). This is a 6 week study which has a 2 week treatment period and a 4 week follow-up evaluation.

NCT ID: NCT01519752 Completed - Tinea Pedis Clinical Trials

A Therapeutic Equivalence Study of Two Oxiconazole Nitrate Topical Cream Treatments for Patients With Tinea Pedis

Start date: November 2011
Phase: Phase 1
Study type: Interventional

The objective of this study is to demonstrate that Oxiconazole nitrate 1% topical cream is effective for the treatment of patients with moderate to severe Tinea pedis.

NCT ID: NCT01433107 Completed - Tinea Pedis Clinical Trials

Efficacy and Safety of Terbinafine Film Forming Solution in Patients With Tinea Pedis

Start date: August 2011
Phase: Phase 3
Study type: Interventional

This study will compare the efficacy and safety of a single dose of terbinafine film forming solution 1% with a single dose of placebo film forming solution in the treatment of tinea pedis.

NCT ID: NCT01396811 Completed - Tinea Pedis Clinical Trials

Topical Antifungal Treatment for Tinea Pedis

Start date: July 2011
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine if a topical antifungal cream is safe and effective for the treatment of tinea pedis.

NCT ID: NCT01396785 Completed - Tinea Pedis Clinical Trials

Topical Antifungal Treatment for Tinea Pedis

Start date: July 2011
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine if a topical antifungal cream is safe and effective for the treatment of tinea pedis.

NCT ID: NCT01358240 Completed - Tinea Pedis Clinical Trials

Safety and Efficacy of Econazole Nitrate Foam 1% and Foam Vehicle in Subjects With Tinea Pedis

Start date: June 2011
Phase: Phase 3
Study type: Interventional

This is a study of the safety and efficacy of Econazole Nitrate Foam 1% and the Foam Vehicle in subjects with interdigital tinea pedis (athlete's foot between the toes). This is a 6 week study which has a 4 week treatment period and a 2 week follow-up evaluation. The study will also utilize Econazole Nitrate Cream 1% (for safety comparison) and a Placebo cream for blinding purposes only.

NCT ID: NCT01353976 Completed - Tinea Pedis Clinical Trials

Safety and Efficacy of Econazole Nitrate Foam 1% in Subjects With Tinea Pedis

Start date: May 2011
Phase: Phase 3
Study type: Interventional

This is a study of the safety and efficacy of topical Econazole Nitrate Foam 1% and the foam vehicle in subjects with interdigital tinea pedis (athlete's foot between the toes). This is a 6 week study which has a 4 week treatment period and a 2 week follow-up evaluation.

NCT ID: NCT01349998 Completed - Tinea Pedis Clinical Trials

Safety of a Topical Antifungal Treatment for Tinea Cruris, Tinea Pedis and Tinea Corporis

Start date: May 2011
Phase: Phase 3
Study type: Interventional

The purpose of this study is to examine the long-term safety of treating recurrent episodes of tinea pedis for 14 days for each recurrence and recurrent episodes of tinea corporis or tinea cruris for 7 days for each recurrence with Product 33525.

NCT ID: NCT01342315 Completed - Tinea Cruris Clinical Trials

Topical Antifungal Treatment for Tinea Cruris

Start date: May 2011
Phase: Phase 3
Study type: Interventional

To determine if a topical antifungal cream is safe and effective for the treatment of tinea cruris

NCT ID: NCT01290341 Completed - Tinea Pedis Clinical Trials

Evaluation of the Efficacy and Safety of NAFT-600 in Subjects With Tinea Pedis

NAFT-600
Start date: February 2011
Phase: Phase 3
Study type: Interventional

This is a 6-week, double-blind, randomized, placebo-controlled, multicenter, parallel group Phase 3 study of NAFT-600 applied once a day for 2 weeks compared to vehicle (placebo) in the treatment of tinea pedis.